We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-17.83%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$404B
AUM Growth
-$174B
Cap. Flow
-$8.47B
Cap. Flow %
-2.09%
Top 10 Hldgs %
31.86%
Holding
14,668
New
1,801
Increased
4,898
Reduced
5,771
Closed
1,897

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$824M
2
QQQ icon
Invesco QQQ Trust
QQQ
+$459M
3
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$301M
4
WBD icon
Warner Bros
WBD
+$287M
5
TSLA icon
Tesla
TSLA
+$230M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.22%
2 Technology 1.79%
3 Consumer Discretionary 1.52%
4 Communication Services 1.04%
5 Financials 1.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RCAT icon
12251
PUT
Red Cat Holdings
RCAT
$1.42B
$23K ﹤0.01%
11,400
+1,300
+13% +$2.58K
RDHL
12252
CALL
Redhill Biopharma
RDHL
$3.83M
$23K ﹤0.01%
26
-39
-60% -$53.5K
SOS
12253
PUT
SOS Limited
SOS
$16.9M
$23K ﹤0.01%
165
-534
-76% -$155K
VINC
12254
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
$23K ﹤0.01%
878
+223
+34% +$9.92K
BTTX
12255
PUT
DELISTED
Better Therapeutics, Inc. Common Stock
BTTX
$23K ﹤0.01%
+14,500
New +$24.3K
EGLX
12256
PUT
DELISTED
Enthusiast Gaming Holdings Inc. Common Stock
EGLX
$23K ﹤0.01%
11,700
-61,300
-84% -$133K
PRTK
12257
CALL
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$23K ﹤0.01%
+12,000
New +$26.2K
QTT
12258
DELISTED
Qutoutiao Inc. American Depositary Shares
QTT
$23K ﹤0.01%
+23,502
New +$26.3K
MTCR
12259
DELISTED
Metacrine, Inc. Common Stock
MTCR
$23K ﹤0.01%
46,864
+16,984
+57% +$8.22K
QNGY
12260
CALL
DELISTED
Quanergy Systems, Inc.
QNGY
$23K ﹤0.01%
2,750
-1,880
-41% -$42.2K
ELTX icon
12261
Elicio Therapeutics
ELTX
$78.6M
$22K ﹤0.01%
+1,934
New +$30.9K
ERNA icon
12262
Eterna Therapeutics
ERNA
$5.45M
$22K ﹤0.01%
+6
New +$43.1K
HOOK
12263
DELISTED
HOOKIPA Pharma
HOOK
$22K ﹤0.01%
+1,321
New +$21.9K
INBS icon
12264
Intelligent Bio Solutions
INBS
$7.11M
$22K ﹤0.01%
+14
New +$23.6K
JAGX icon
12265
CALL
Jaguar Health
JAGX
$4.47M
0
NNVC icon
12266
CALL
NanoViricides
NNVC
$32.7M
$22K ﹤0.01%
11,800
-3,700
-24% -$6.8K
TMQ
12267
Trilogy Metals
TMQ
$651M
$22K ﹤0.01%
29,174
-17,766
-38% -$17.6K
WWR icon
12268
PUT
Westwater Resources
WWR
$76.1M
$22K ﹤0.01%
20,400
-14,000
-41% -$18.2K
YCBD icon
12269
PUT
cbdMD
YCBD
$5.66M
$22K ﹤0.01%
136
-15
-10% -$3.55K
ABTC
12270
American Bitcoin Corp
ABTC
$637M
$22K ﹤0.01%
5
-3
-38% -$51.5K
GRCE
12271
Grace Therapeutics
GRCE
$45.6M
$22K ﹤0.01%
+4,327
New +$26.3K
DOMA
12272
PUT
DELISTED
Doma Holdings, Inc.
DOMA
$22K ﹤0.01%
856
-3,784
-82% -$161K
AGRX
12273
DELISTED
Agile Therapeutics
AGRX
$22K ﹤0.01%
371
+337
+991% +$48.9K
ZY
12274
CALL
DELISTED
Zymergen Inc. Common Stock
ZY
$22K ﹤0.01%
18,200
-1,100
-6% -$1.84K
DAVE icon
12275
PUT
Dave Inc
DAVE
$4.76B
$21K ﹤0.01%
972
+425
+78% +$41.2K

Similar funds

Jeff Yass's Q2 2022 Portfolio in Review

As of Q2 2022, Jeff Yass held 14,668 positions worth $404B, down 30% from $578B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q2 2022 filing shows 1,801 new, 4,898 increased, 5,771 reduced and 1,897 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $1.88B.

By sector, the portfolio is most concentrated in Miscellaneous at 92% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q2 2022 buy was iShares US Treasury Bond ETF: 1,544,259 shares worth $36.9M.
  • Jeff Yass added most to Amazon in Q2 2022, an estimated $824M increase.
  • Jeff Yass's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.88B.
  • Jeff Yass fully exited Discovery, Inc. Series C Common Stock in Q2 2022, selling an estimated $176M.
  • Jeff Yass's ten largest holdings make up 32% of its $404B portfolio in Q2 2022.
  • Jeff Yass opened 1,801 new positions and closed 1,897 in Q2 2022.
  • Jeff Yass's portfolio value fell 30% quarter-over-quarter to $404B.

Based on Susquehanna International Group's 13F filing for Q2 2022, filed 15 Aug 2022.